Is carboplatin plus gemcitabine therapy beneficial in locally advanced or metastatic non-small-cell lung cancer?

Abstract

DESIGN Between October 1988 and January 2001, this study enrolled patients with AJCC stage IIIB or IV NSCLC who were not candidates for surgery or curative radiation and had not previously been treated with chemotherapy. Patients were randomized to receive gemcitabine or gemcitabine+carboplatin. Inclusion criteria were WHO performance status 0–2, age ≥18… (More)
DOI: 10.1038/ncponc0513

Topics

Cite this paper

@article{Spiro2006IsCP, title={Is carboplatin plus gemcitabine therapy beneficial in locally advanced or metastatic non-small-cell lung cancer?}, author={Stephen G. Spiro}, journal={Nature Clinical Practice Oncology}, year={2006}, volume={3}, pages={358-359} }